Molecular Dx firm GeneNews eyes $7.8M from share offering

12/18/2012 | GenomeWeb Daily News (free registration)

GeneNews, a molecular diagnostics firm based in Toronto, hopes to obtain $7.8 million in a private offering of its company stock. The company is in talks to expand the reach of its ColonSentry blood-based assay for colon cancer stratification, which is currently available in New York and New Jersey, across the rest of the U.S., President and CEO Gailina Liew said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA